SCHEMBL12762299

SCHEMBL12762299

NC(=O)CCc1cc(=O)oc2c1ccc1ccccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.52
▸ MTNR1A P48039 1/20 0.45
▸ MAPT P10636 2/20 0.44
▸ PRKDC P78527 3/20 0.44
▸ HPGD P15428 4/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ LMNA P02545 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MCL1 Q07820 1/20 0.42
▸ HSD17B10 Q99714 2/20 0.41
▸ CYP1A1 P04798 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP1B1 Q16678 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ PDE5A O76074 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12762291 0.88 KMT2A (0.54) KMT2AMAPTPRKDCHPGDALDH1A1
SCHEMBL20100779 0.79 KMT2A (0.67) KMT2AMAPTPRKDCHPGDALDH1A1
SCHEMBL17383983 0.77 KMT2A (0.60) KMT2AMAPTPRKDCHPGDALDH1A1
SCHEMBL2726345 0.74 KMT2A (0.68) KMT2AMAPTPRKDCHPGDALDH1A1
SCHEMBL2761855 0.72 KMT2A (0.66) KMT2AMAPTPRKDCHPGDALDH1A1
SCHEMBL14424528 0.72 KMT2A (0.70) KMT2AMAPTPRKDCHPGDALDH1A1
SCHEMBL961507 0.72 MTNR1A (0.63) KMT2AMTNR1AHPGDKDM4ECYP1A2
SCHEMBL18892727 0.71 MTNR1A (0.50) MTNR1ACYP1A1CYP1B1
SCHEMBL17384175 0.70 KMT2A (0.51) KMT2AMAPTPRKDCHPGDALDH1A1
SCHEMBL6172772 0.70 MTNR1A (0.52) MTNR1AHPGDKDM4EL3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7897736-B2 Fluorescent quenching detecting reagents and methods ELITECH HOLDING B.V. (NL) 2011-03-01 — — US disclosed
US-20100174058-A1 FLUORESCENT QUENCHING DETECTING REAGENTS AND METHODS ELITECHGROUP, INC. 2010-07-08 — — US disclosed
US-7662942-B2 Oligonucleotide probes containing two labels useful in hybridization assays Elitech Holdings, B.V. (NL) 2010-02-16 — — US disclosed
US-7662942-B2 Oligonucleotide probes containing two labels useful in hybridization assays Elitech Holdings, B.V. (NL) 2010-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100174058-A1 FLUORESCENT QUENCHING DETECTING REAGENTS AND METHODS DDX5, DDX21, DCLRE1B KMT2A 4027/4885MTNR1A 2967/4885MAPT 4706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback